Matters-of-concern’ associated with discontinuation of long-acting injectable buprenorphine
Findings from a longitudinal qualitative study
Dados Bibliográficos
| ID | 14907871 |
|---|---|
| Autores | Parkin (0000-0003-1621-0945, London School of Hygiene & Tropical Medicine, autor correspondente), Joanne Neale (0000-0003-1502-5983, King's College London), John Strang (0000-0001-9142-210X) |
| Ano | 2024 |
| Volume | 129 |
| Páginas | 104470 |
| Data de publicação | 2024-07-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2024.104470 |
| PMID | 38843737 |
| OpenAlex | W4399454687 |
| Idioma | EN |
| Citações recebidas | 8 |
| Referências citadas | 52 |
Anesthesia · Buprenorphine · De-escalation · Discontinuation · Intensive care medicine · Methadone · Opioid · Perspective (graphical · Psychiatry · Qualitative research · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Pain Management and Opioid Use · Internal Medicine
Long-Acting Injectable Buprenorphine for Opioid Use Disorder
Patient satisfaction with long-acting injectable buprenorphine
Reported patient experiences of extended-release buprenorphine for opioid dependence
Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
The matter of mattering in depot buprenorphine treatment
The benefits and potential biases of lived experience in substance use treatment services
Initiation, retention, and discontinuation of extended-release buprenorphine (BUP-XR) for opioid dependence
The ‘knowing’ body in the becoming of buprenorphine depot treatment
The role of the therapeutic alliance in psychotherapy.
Dropout rates of in‐person psychosocial substance use disorder treatments
Drop-out from addiction treatment
Dropping out of substance abuse treatment
Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder
Qualitative study of patients’ decisions to initiate injectable depot buprenorphine for opioid use disorder
Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence
Risk Factors for Treatment Drop-Out
Habits
Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey
Towards “evidence-making intervention” approaches in the social science of implementation science
Opioid overdose reversals using naloxone in New York City by people who use opioids
Can a new formulation of opiate agonist treatment alter stigma
The dynamics of more-than-human care in depot buprenorphine treatment
Reprint of
I just thought that was the best thing for me to do at this point’
Tinkering with care
Dropping out of treatment
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence
Recasting Participation in Drug Policy
Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases
The Many Faces of RU486
Resisting medicines
Evidence-making interventions in health
Living with the deceased
The becoming-methadone-body
| Obras citantes distintas | 8 |
|---|---|
| Citações por ano | 4 |
| Intervalo de citações | 2024 - 2026 (3) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 8 |